Andrea Lotta
New perspectives on the use of cannabis in the treatment of psychiatric disorders
Maria Scherma;Paolo MasiaWriting - Original Draft Preparation
;DEIDDA, MATTEOWriting - Original Draft Preparation
;Walter FrattaWriting - Review & Editing
;Paola Fadda Writing - Original Draft Preparation
2018-01-01
Abstract
Following the discovery of the endocannabinoid system and its potential as a therapeutic target for various pathological conditions, growing interest led researchers to investigate the role of cannabis and its derivatives for medical purposes. The compounds Δ9-tetrahydrocannabinol and cannabidiol are the most abundant phytocannabinoids found in cannabis extracts, as well as the most studied. The present review aims to provide an overview of the current evidence for their beneficial effects in treating psychiatric disorders, including schizophrenia, anxiety, and depression. Nevertheless, further investigations are required to clarify many pending issues, especially those relative to the assessment of benefits and risks when using cannabis for therapeutic purposes, thereby also helping national and federal jurisdictions to remain updated.File | Size | Format | |
---|---|---|---|
Scherma et al, medicine 2018.pdf open access
Type: versione editoriale
Size 724.88 kB
Format Adobe PDF
|
724.88 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.